The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients.
about
The effects of oxidative stress on female reproduction: a reviewD-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review.Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.Downregulated expression of peroxiredoxin 4 in granulosa cells from polycystic ovary syndrome.Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes lipid peroxidation, protein oxidation and DNA damage in lymphoblastoid B cell linesCould oxidative stress influence the in-vitro maturation of oocytes?Alterations in the levels of plasma amino acids in polycystic ovary syndrome--A pilot study.Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4+ T cellsEffect of Ubiquinol on Serum Reproductive Hormones of Amenorrhic Patients.Oxidative stress and antioxidants: exposure and impact on female fertilityRelationship between IL-17 serum level and ambulatory blood pressure in women with polycystic ovary syndrome.Thyroid function and pregnancy: before, during and beyond.Urinary phthalate and phthalate alternative metabolites and isoprostane among couples undergoing fertility treatment.Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies.2.45 GHz microwave irradiation-induced oxidative stress affects implantation or pregnancy in mice, Mus musculus.Involvement of lipid peroxidation-derived aldehyde-protein adducts in autoimmunity mediated by trichloroethene.Extended high frequency audiometry in polycystic ovary syndrome.Genetic association of CTLA4 gene with polycystic ovary syndrome in the Chinese Han population
P2860
Q28392215-D1A58FA5-EFDF-479D-A1A0-70A6F90E06B6Q34153910-8C3A95E1-8BF9-4738-96EA-90728E22F9FAQ34321879-7A94CD33-0B0C-4282-B676-6006E2AEE776Q35009453-07CA6E8E-80D6-4E4B-BA2A-A785A7CC9328Q35137340-86DF5D52-6B1B-4A8B-A91D-4CA50E03566DQ35606245-68CF0EE7-7038-4724-A1B4-521DF999AA36Q36550171-DAAB4D46-68BC-44B7-8CC5-AEAB9051D58EQ36737666-AB3D98E9-EA57-48BB-8528-2BAC91AC9E9AQ37013015-CA408586-D5EA-4525-B38F-3B8C488627ADQ37183847-8A5F2340-F27F-46E4-9CF7-15BA02C013F8Q37410552-F99C609C-ECF6-481C-AD97-8FBB5F194EC5Q37815179-E4D2FF33-DAFA-4571-B195-8D4184D0B7EAQ39163095-49C336E5-1DF0-406D-A018-95897F2A806FQ43080330-A079589C-5420-4D20-8077-44888353CCC2Q43499891-BB3B132B-7DC0-474B-94DB-CB86DF741C43Q46926946-A72A3AB4-FD93-4896-8B42-E7EE20D45A47Q51331797-F3809D5C-BA1A-40C2-9B4B-B8E179164CF2Q56891518-E3B19CD3-BA8E-4F1E-BA6C-F5EE01906755
P2860
The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The presence of antibodies to ...... ystic ovary syndrome patients.
@ast
The presence of antibodies to ...... ystic ovary syndrome patients.
@en
The presence of antibodies to ...... ystic ovary syndrome patients.
@nl
type
label
The presence of antibodies to ...... ystic ovary syndrome patients.
@ast
The presence of antibodies to ...... ystic ovary syndrome patients.
@en
The presence of antibodies to ...... ystic ovary syndrome patients.
@nl
prefLabel
The presence of antibodies to ...... ystic ovary syndrome patients.
@ast
The presence of antibodies to ...... ystic ovary syndrome patients.
@en
The presence of antibodies to ...... ystic ovary syndrome patients.
@nl
P2860
P50
P1476
The presence of antibodies to ...... cystic ovary syndrome patients
@en
P2093
Z Ulcova-Gallova
P2860
P304
P356
10.1111/J.1365-2249.2006.03061.X
P577
2006-05-01T00:00:00Z